Profound hypothermia with circulatory arrest is an important surgical adjuvant that allows protected cessation of cerebral blood flow for a brief period. In seven patients undergoing this procedure, continuous spectroscopic measurement of cerebral hemoglobin oxygen saturation was performed. Circulatory arrest at 18°C was associated with a significant progressive desaturation (p < 0.01) of residual cerebral hemoglobin. Arrest time varied based on operative complexity (range 10 to 65 minutes), and a negative linear correlation between arrest time (y) and oxygen saturation (x) was noted (y = -0.87x + 64). Five patients whose saturation remained above 35% had no neurological injury attributable to hypoxia. One patient (Hunt and Hess Grade 0) whose saturation fell below 35% had evidence of a global hypoxic injury at postmortem examination. Spectroscopically measured cerebral hemoglobin saturation (cerebral oximetry) may be used to monitor metabolic activity during circulatory arrest. Although the clinical utility of such monitoring cannot be established at this time, the potential may exist to prolong the safe duration of induced circulatory arrest for cerebral protection.
S
EVERAL centers have demonstrated renewed interest in using profound hypothermia with induced circulatory arrest as a surgical adjunct for the management of complex cerebrovascular disease."' This practice allows temporary collapse of large aneurysmal sacs, control of the parent vessel, and transient neuronal protection from hypoxia.'°• 12." A major limitation of this adjunct is that cerebral oxygen delivery is completely stopped while cerebral oxygen metabolism (although greatly reduced by profound hypothermia) continues. Cerebral oxygen extraction during profound hypothermia has been demonstrated in animal models.''' The discrepancy between cerebral oxygen delivery and consumption during protected circulatory arrest limits the time period during which hypothermic neuronal protection is efficacious.
The period of "safe" circulatory arrest during profound hypothermia is apparently quite variable in both laboratory and clinical work.1-3,10,I2,21,23,2830, 32 The determinants of safe arrest time in a given individual are poorly defined and traditional intraoperative monitoring paradigms are not capable of such determination.
Near-infrared light (650 to 1100 nm) is capable of penetrating human tissue to a depth of several centimeters.'" Because attenuation of this light in tissue is heavily dependent on the extent of hemoglobin oxygen binding, infrared transmission spectroscopy can be used to measure tissue hemoglobin oxygen saturation. 5,6,9,16,17.19.31,38 This technology forms the basis of peripheral pulse oximetry, which is commonly used in clinical practice for monitoring arterial oxygen saturation. 7 ." 33 Advances in optoelectronics have made it possible to perform infrared transmission spectroscopy on tissue below the level of the dermis, including the cerebral cortex." 7.19 '27 The spectra obtained can be used to measure hemoglobin oxygen saturation in the cerebral vasculature, which is primarily venous blood.' 7 ."•" This quantitative parameter, "cerebrovascular saturation," is very sensitive to human cerebral hypoxia. ' Because oxyhemoglobin and deoxyhemoglobin have unique absorption profiles in the near-infrared spectrum and these two molecules represent the significant tissue chromophores, a tissue content ratio of the two can be determined." The content ratio (oxyhemoglobin:deoxyhemoglobin) can be converted to the clinically recognizable parameter of percent hemoglobin oxygen saturation."• 19 An aggregate saturation of the hemoglobin is present in the arteries, veins, and capillaries of the brain, but measurement of oxygen saturation primarily represents cerebral venous saturation." , 2°." Venous blood volume accounts for approximately 80% of total cerebral blood volume. 2°• 27 This report describes the changes in human cerebrovascular saturation during profound cerebral cooling, circulatory arrest, and cerebral reperfusion. The measurements were made in seven patients during complex cerebral aneurysm repair.
Clinical Material and Methods

Patient Population
The seven patients ranged in age from 17 to 64 years (average 46 years). Five aneurysms were located in the posterior circulation, including two at the basilar tip, one midbasilar, one arising from the vertebral artery, and one from the posterior inferior cerebellar artery. The two aneurysms in the anterior circulation included a fusiform aneurysm of the M I segment of the middle cerebral artery and a fusiform aneurysm of the distal internal carotid artery (ICA) including the bifurcation. Two patients presented with acute subarachnoid hemorrhage; both were in Hunt and Hess Grade III.' One of these two patients rebled just prior to surgery and deteriorated to Grade IV.
Patients requiring the profound hypothermia protocol underwent extensive preoperative evaluation. Every patient underwent computerized tomography and magnetic resonance imaging of the brain, as well as fourvessel cerebral angiography. Five of the seven patients were subjected to further cerebral angiography, including superselective single intracranial vessel angiograms and vessel test occlusions. Every patient was evaluated by a cardiologist and had an electrocardiogram, rhythm strip, and echocardiogram preoperatively. Patients with cardiac symptoms and those over 50 years of age were given coronary angiograms. A preoperative coagulation profile, including a test of platelet function (Sona clot), was obtained in every case.
Operative Procedure
The details of perioperative patient management and the use of a femoral-femoral bypass for cooling and cerebral or cardiac arrest have been previously described.3,26,28 All patients had peripheral arterial line and Swan-Ganz catheters inserted prior to anesthesia. Anesthesia was induced with an intravenous injection of thiopental (2 to 3 mg/kg), sufentanil (1 to 3 izg/kg), lidocaine (1.5 mg/kg), and the muscle relaxant vecuronium (0.15 mg/kg). A standard anesthetic maintenance regimen was used in all patients, consisting of isoflurane (0.5 to 1 vol%), sufentanil (0.3 to 0.5 Ag/kg/ hr), thiopental (0. to 0.2 mg/kg/min), and vecuronium (titrated to no twitch response on a neuromuscular blockage monitor). The patient's temperature was allowed to decrease passively to 32° to 33°C. After adequate surgical exposure and dissection, systemic heparinization was achieved with a heparin loading dose (3 mg/kg) followed by small boluses to maintain an activated clotting time of at least 450 seconds. The fernoral-femoral bypass was performed and the patient's temperature (tympanic) was allowed to reach 17°C. At an average temperature of 28 ± 3°C, spontaneous asystole occurred. The average elapsed time for cooling was 43 ± 22 minutes. During reperfusion, the patient's temperature was gradually increased to 37°C. Cardiac activity was seen at approximately 28°C. Anticoagulation was reversed using protamine sulfate.
Spectroscopic Measurement
Prior to surgery in each case, a two-channel, multiple wavelength, tissue infrared spectrometer* was placed. The optoelectronic-patient interface was placed on the patient's shaved scalp in the region of the middle frontal gyms on the nonoperated side, using customized fiberoptic cables and photodiodes on miniaturized printed circuit boards configured in a sealed unit. This hardware has been described in detail elsewhere."' Optical coupling to the scalp was protected from ambient light with an adhesive shield. The light source had a 0.5-mm diameter, and two receivers were placed 1.0 and 2.7 cm from the center of the light source. The configuration of the infrared source and receiver mounted in this fashion has been shown to measure light attenuation in the human cerebrovascular compartment.
Infrared transmission attenuation at five wavelengths (650, 726, 750, 803, and 840 nm) was measured and updated at 3.0-msec intervals. Attenuation at each wavelength was analyzed according to the Beer-Lambert law: -In lodImo = In this expression, I(w) represents the intensity of transmitted light at wavelength w, I(w)0 represents the intensity of the incident light at wavelength w, a represents the molar extinction coefficient of oxyhemoglobin or hemoglobin, C represents the concentration of the molecule in the tissue, and s represents the photon pathlength in the tissue. Tissue photon pathlength is not directly measurable with current clinical technology, and this variable is treated as a constant over the narrow wavelength band of 650 to 900 nm. The near-infrared scattering profile of fresh brain over this wavelength band is relatively flat.'' Spectroscopic measurements made during passive cooling, active cooling, circulatory arrest, and reperfusion were divided into 3-minute epochs. There were a total of 33 measurements (Fig. 1) . The 3-minute epochs at the end of passive cooling, active cooling, and circulatory arrest and immediately following reperfusion were considered representative of these major intraoperative phases and were statistically compared by analysis of variance.
Cerebrovascular saturation measurements were stored every 5.5 seconds during patient cooling, circu- latory arrest, and rewarming. Simultaneous recordings of mean arterial blood pressure and temperature were continuously monitored.
Results
No significant difference was found between cerebrovascular saturation measurements during passive cooling, active cooling, and reperfusion (Fig. 2) . There was a significant difference (p < 0.01) between each of the above conditions and circulatory arrest. This difference demonstrated desaturation during circulatory arrest and resaturation during reperfusion.
The duration of circulatory arrest varied from 10 to 65 minutes and had a negative linear correlation with cerebrovascular saturation (seven cases, r = -0.87, s = 7) (Fig. 3) . The smallest drop in saturation recorded was 15%. At the opposite extreme, in one patient cerebrovascular saturation fell to 30% after 45 minutes of circulatory arrest, and in another saturation fell to, but not below, 34% after 65 minutes of arrest. These two patients with prolonged circulatory arrest periods (45 and 65 minutes) had a poor outcome. The first was in Grade IV going into surgery and the outcome may not be related to the duration of circulatory arrest. The second, however, was in Grade 0 preoperatively. This patient required extensive reconstruction of the ICA bifurcation during clipping, resulting in a prolonged period of cardiac arrest. Postoperatively the patient failed to regain consciousness, and an electroencephalogram (EEG) was consistent with profound encephalopathy. Postmortem examination revealed the immediate cause of neurological deterioration to be a 1.0 x 0.5-cm pontine hemorrhage, but in addition cellular changes consistent with diffuse cerebral ischemia were observed.
Of the remaining five patients, four had an excellent outcome and returned to premorbid levels of activity. One patient had a good outcome with a mild new left hemiparesis.
Discussion
Measurement Methodology
It is firmly established that near-infrared light penetrates human tissue to a depth of several centimeters.9'27" This light is attenuated during transmission through tissue by both scattering and absorption. Absorption is due primarily to the few molecules in human tissue that absorb near-infrared light, including hemoglobin, oxyhemoglobin, and cytochrome aa 3. 13, 25, 36 Because cerebral hemoglobin content is approximately 600 mg/100 gm tissue and is several orders of magnitude higher than cytochrome aa 3 content, hemoglobin accounts for the majority of absorption events. Transmission attenuation, therefore, can be used to quantify changes in hemoglobin oxygen saturation in cerebral tissue. Using a pulse-gated signal from a distal appendage, the primarily arterial oxyhemoglobin signal can be correlated with measured arterial saturation. This is the basis of pulse oximetry.
Transmission measurements through deeper tissues including the scalp, skull, and brain are possible.' Several investigators have reported direct transillumination spectroscopy of the adult human cerebrum."" Recently, the concept of diffuse transmission spectroscopy has been adapted for generating cerebral transmission spectra. This involves the use of a single infrared point source and one or more diode receivers placed 1 cm or more from the source. 17-' 9." In this arrangement, light propagates along a high probability course into the tissue of interest and then back to the sur- . Note that in no patient did saturation fall below 30%, which at 18°C equals a p02 of 7 to 10 torr. This is illustrated by the broken line demarcating the 30% saturation level.
face. 4, 22, 23 This process has the unique advantage of depth resolution, which allows cerebral hemoglobin to be measured independently of scalp and skull hemoglobin. ' In deep tissue spectroscopy, all hemoglobin (arterial, capillary, and venous) contributes to the measured saturation; in the case of cerebral hemoglobin, this aggregate measurement is referred to as "cerebrovascular" saturation. However, venous blood represents approximately 75% to 80% of cerebrovascular hemoglobin, making the measurement most sensitive to changes in cerebral venous saturation.
2o. 2 ' The instrumentation used in this study has been demonstrated to detect changes in scalp and skull attenuation of infrared light independent of cerebral attenuation in patients undergoing carotid endarterectomy.' In addition, the spectroscopy algorithm used here to quantify hemoglobin saturation is more sensitive to human hypoxia than an analog EEG and correlates with mixed cerebral venous saturation in humans. 18 In patients undergoing hypothermic circulatory arrest, the major cortical arteries and veins empty and become pale white. Under these conditions, hemoglobin remaining in the microcirculation becomes the predominant source of infrared light attenuation. The oxygen saturation of this residual hemoglobin can be followed during circulatory arrest.
Cerebral Protection During Hypothermia
Hypothermia is known to reduce the neuronal injury associated with hypoxia.'' 2 ' 20 .2931 The mechanism of action is related to a reduction in metabolic rate and therefore in the oxygen requirements of neurons. This reduction in metabolism is commonly quantified as the change in metabolic rate of the tissue for every 10°C decrease in temperature (Q, o), as follows: Q, o = (Rd Rem -T2) , rate at temperatures T 1 and T2, respectively. In humans the metabolic rate is approximately halved with a 10°C decrease in temperature (0, 0 = 2).
Tanaka, et al.,' studied cerebral metabolism in dogs over a temperature range of 20° to 37°C. At 20°C the cerebral metabolic rate of oxygen was reduced to 18% ± 2% of baseline, demonstrating that, although cellular oxygen demand is reduced, it is not zero. Stocker, et al.,' studied the half-life times of high-energy phosphates in rabbits undergoing hypothermic circulatory arrest. They were unable to identify a temperature below which cerebral oxygen metabolism stopped; the lowest temperature tested was 21°C.
Because cellular oxygen demand persists during hypothermic circulatory arrest and oxygenated blood is left behind in the microcirculation of the brain, oxygen should move down its partial pressure of oxygen (p02) gradient to the mitochondria. Mitochondrial p0 2 is normally 3 to 8 torr, giving a gradient of greater than 80 torr between the capillary and the mitochondria. As the partial pressure of residual cranial blood drops, the hemoglobin will desaturate. Desaturation at these temperatures is not favorable because the affinity of hemoglobin for oxygen increases as temperature drops.'
At 20°C a hemoglobin saturation of 30% will be associated with a p02 of 7 to 10 torn At this p02 there is no longer a capillary-to-mitochondria gradient and hemoglobin desaturation stops. This may explain why a drop below 30% saturation was not detected in our patients. In the patient with a 45-minute cardiac arrest, a saturation of 30% was reached and, in the one whose arrest lasted an additional 20 minutes, the lowest saturation reached was 34%.
During circulatory arrest, residual microcirculatory oxyhemoglobin will theoretically act as an oxygen reserve to maintain cellular metabolism. This situation is fundamentally analogous to critical tissue p0 2 (or venous p02). 37 Here cerebral oxygen metabolism is availability-dependent and, as oxyhemoglobin desaturation proceeds, the p02 gradient diminishes. When the gradient is insufficient to meet metabolic demand, lactic acid production and hypoxic cellular injury result.
The point at which hypoxic cellular injury begins is uncertain, but it would logically occur following the critical point where anaerobic metabolism begins. This suggests that keeping residual hemoglobin saturation well above 30% at 18°C may prolong neuronal protection.
The limit of the oxyhemoglobin reserve is determined by the amount of residual oxyhemoglobin, the metabolic rate of oxygen (positively correlated with temperature), and the affinity of hemoglobin for oxygen (negatively correlated with temperature). Therefore, the residual oxyhemoglobin utilization hypothesis predicts that in each patient an arrest temperature exists where cerebral oxygen metabolism and cerebral oxygen availability are optimized for best cerebral protection during ischemic hypoxia.
The existence of an optimum temperature is demonstrable. The neurological tolerance of baboons to hypothermic circulatory arrest is worse at 10°C and at 15°C (RS Zimmerman, et al., unpublished data). An where R I and R2 represent the metabolic explanation for this observation might be an available oxygen reserve.
Progressive Hypothermia and Cerebrovascular Saturation
Cerebrovascular saturation did not change significantly during progressive cooling in these patients. Assuming that metabolic demand for oxygen decreases during hypothermia, one might expect an increase in cerebral venous saturation and therefore in cerebrovascular saturation. The fact that this did not occur in the group as a whole demonstrates intact oxygen delivery, or oxygen metabolism coupling. Metabolic autoregulation is known to be preserved during hypothermia in humans.'
Reperfusion and Cerebrovascular Saturation
Reperfusion following circulatory arrest is a critical event because it re-establishes oxygen delivery to the brain and usually begins the rewarming process. It is known that the rewarming period is a high-risk time for brain injury because metabolic needs may outstrip oxygen delivery at various temperatures, both regionally and globally.' In our patients saturation rapidly returned to near baseline levels. However, due to the temperature dependence of both hemoglobin oxygen affinity and cerebral metabolic demand, this return to baseline saturation may not prevent episodes of tissue hypoxia during rewarming. In addition, following arrest, the tissue may be abnormal with exhausted homeostatic reserves, absent ionic gradients, and decompartmentalized neurotransmitters; any of these phenomena may increase metabolic demand from baseline.
In two patients the return of saturation to pre-arrest levels was delayed by several minutes despite the fact that postarrest patient temperature and cerebral oxygen delivery were similar to the pre-arrest levels. This delay was not related to prolonged arrest (less than 40 minutes in both patients) but may represent an increased metabolic rate of oxygen, as expected following hypoxia.
Patient Management Implications
Noninvasive cerebral hemoglobin saturation (cerebral oximetry) can be used to monitor the oxygen reserve of cells during circulatory arrest. Assuming that oxygen available from this reserve is necessary for cellular integrity, then monitoring it may allow arrest time to be tailored to prevent hypoxic injury.
One management paradigm recently employed in a patient not included in this series was to reperfuse the brain after 33 minutes of arrest, when cerebrovascular saturation had dropped to 45%. Reperfusion lasted 5 minutes and circulatory arrest was then reintroduced for 12 minutes to finish the operation. At the end of the second arrest period, saturation had dropped to 54%. The total arrest time was 52 minutes and the patient made a complete recovery, returning to premorbid activity levels.
Although cerebral oximetry is potentially clinically useful in monitoring cerebral oxygen saturation and thus indirectly cerebral metabolism, not enough data exist to recommend its routine use for evaluating the safety of controlled circulatory arrest. As clinical experience with such real-time measurements increases, it is hoped that a management strategy extending the safe time limit of adjuvant hypothermic circulatory arrest will be established. Used in this fashion, cerebral oximetry may prolong the duration of safe circulatory arrest in humans.
Conclusions
In seven patients undergoing elective hypothermic circulatory arrest for aneurysm repair, ongoing cerebral oxygen metabolism was identified. This metabolic activity is consistent with animal data. Oxygen is supplied by an oxyhemoglobin reserve in the microcirculation, which may be directly monitored by infrared spectroscopy. A negative linear correlation between residual hemoglobin saturation and duration of arrest was observed, and a lower limit of desaturation may exist at 30%. Continuous monitoring of such cerebral saturation may allow for management strategies that extend the safe time limit of adjuvant hypothermic circulatory arrest.
